CD34 positive cells as endothelial progenitor cells in biology and medicine

CD34 is a cell surface antigen expressed in numerous stem/progenitor cells including hematopoietic stem cells (HSCs) and endothelial progenitor cells (EPCs), which are known to be rich sources of EPCs. Therefore, regenerative therapy using CD34+ cells has attracted interest for application in patients with various vascular, ischemic, and inflammatory diseases. CD34+ cells have recently been reported to improve therapeutic angiogenesis in a variety of diseases. Mechanistically, CD34+ cells are involved in both direct incorporation into the expanding vasculature and paracrine activity through angiogenesis, anti-inflammatory, immunomodulatory, and anti-apoptosis/fibrosis roles, which support the developing microvasculature. Preclinical, pilot, and clinical trials have well documented a track record of safety, practicality, and validity of CD34+ cell therapy in various diseases. However, the clinical application of CD34+ cell therapy has triggered scientific debates and controversies in last decade. This review covers all preexisting scientific literature and prepares an overview of the comprehensive biology of CD34+ cells as well as the preclinical/clinical details of CD34+ cell therapy for regenerative medicine.

[1]  Yang Liu,et al.  Endothelial progenitor cell (EPCs)-derived exosomal miR-30d-5p inhibits the inflammatory response of high glucose-impaired fibroblasts by affecting the M1/M2 polarization of macrophages , 2022, Revista Romana de Medicina de Laborator.

[2]  T. Asahara,et al.  Characterization of Endothelial Progenitor Cell: Past, Present, and Future , 2022, International journal of molecular sciences.

[3]  M. Fukushima,et al.  Pre-Clinical Proof of Concept: Intra-Carotid Injection of Autologous CD34-Positive Cells for Chronic Ischemic Stroke , 2022, Frontiers in Medicine.

[4]  M. Ratajczak,et al.  Human CD34+ very small embryonic-like stem cells can give rise to endothelial colony-forming cells with a multistep differentiation strategy using UM171 and nicotinamide acid , 2022, Leukemia.

[5]  T. Henry,et al.  Autologous CD34+ Stem Cell Therapy Increases Coronary Flow Reserve and Reduces Angina in Patients With Coronary Microvascular Dysfunction , 2022, Circulation. Cardiovascular Interventions.

[6]  M. Bell,et al.  IMPROvE-CED Trial: Intracoronary Autologous CD34+ Cell Therapy for Treatment of Coronary Endothelial Dysfunction in Patients With Angina and Nonobstructive Coronary Arteries , 2021, Circulation research.

[7]  F. Yan,et al.  Paracrine mechanisms of endothelial progenitor cells in vascular repair. , 2021, Acta histochemica.

[8]  T. Asahara,et al.  Acute kidney injury successfully treated with autologous granulocyte colony‐stimulating factor‐mobilized peripheral blood CD34‐positive cell transplantation: A first‐in‐human report , 2021, Stem cells translational medicine.

[9]  Xue Han,et al.  Endothelial progenitor cells-derived exosomal microRNA-21-5p alleviates sepsis-induced acute kidney injury by inhibiting RUNX1 expression , 2021, Cell Death & Disease.

[10]  Shouheng Lin,et al.  Umbilical cord blood CD34+ cells administration improved neurobehavioral status and alleviated brain injury in a mouse model of cerebral palsy , 2021, Child's Nervous System.

[11]  Xun Hu,et al.  Exosomal miR-218-5p/miR-363-3p from Endothelial Progenitor Cells Ameliorate Myocardial Infarction by Targeting the p53/JMY Signaling Pathway , 2021, Oxidative medicine and cellular longevity.

[12]  U. Bayraktutan,et al.  The secretome of endothelial progenitor cells: a potential therapeutic strategy for ischemic stroke , 2021, Neural regeneration research.

[13]  Yanfang Chen,et al.  Rab27a deletion impairs the therapeutic potential of endothelial progenitor cells for myocardial infarction , 2020, Molecular and Cellular Biochemistry.

[14]  Tao Dong,et al.  Endothelial progenitor cell-derived exosomes ameliorate endothelial dysfunction in a mouse model of diabetes. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[15]  L. Stanberry,et al.  CD34 + cell therapy significantly reduces adverse cardiac events, health care expenditures, and mortality in patients with refractory angina , 2020, Stem cells translational medicine.

[16]  Mingwei Chen,et al.  miRNA-221-3p in Endothelial Progenitor Cell-Derived Exosomes Accelerates Skin Wound Healing in Diabetic Mice , 2020, Diabetes, metabolic syndrome and obesity : targets and therapy.

[17]  Mel S. Lee,et al.  Safety and efficacy of intrarenal arterial autologous CD34+ cell transfusion in patients with chronic kidney disease: A randomized, open‐label, controlled phase II clinical trial , 2020, Stem cells translational medicine.

[18]  M. Chopp,et al.  CD133+Exosome Treatment Improves Cardiac Function after Stroke in Type 2 Diabetic Mice , 2020, Translational Stroke Research.

[19]  Cheng Hu,et al.  Endothelial progenitor cells promote viability and nerve regenerative ability of mesenchymal stem cells through PDGF-BB/PDGFR-β signaling , 2020, Aging.

[20]  S. Ran,et al.  Lymphatic Endothelial Cell Progenitors in the Tumor Microenvironment. , 2020, Advances in experimental medicine and biology.

[21]  Ran Sun,et al.  Mobilization of endothelial progenitor cells in sepsis , 2019, Inflammation Research.

[22]  Claire N. Medine,et al.  Endothelial Progenitor Cells Do Not Originate From the Bone Marrow , 2019, Circulation.

[23]  B. Vrtovec,et al.  Transendocardial CD34+ Cell Therapy does not Increase the Risk of Ventricular Arrhythmias in Patients with Chronic Heart Failure , 2019, Cell transplantation.

[24]  C. P. Vicente,et al.  Administration of endothelial progenitor cells accelerates the resolution of arterial thrombus in mice. , 2019, Cytotherapy.

[25]  D. Kolte,et al.  Intramyocardial autologous CD34+ cell therapy for refractory angina: A meta-analysis of randomized controlled trials. , 2019, Cardiovascular revascularization medicine : including molecular interventions.

[26]  Pengfei Li,et al.  Exosomes from endothelial progenitor cells improve outcomes of the lipopolysaccharide-induced acute lung injury , 2019, Critical Care.

[27]  C. Borlongan,et al.  Endothelial Progenitor Cells Modulate Inflammation-Associated Stroke Vasculome , 2019, Stem Cell Reviews and Reports.

[28]  Yu Wang,et al.  G-CSF-induced macrophage polarization and mobilization may prevent acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation , 2019, Bone Marrow Transplantation.

[29]  Li Zhao,et al.  MicroRNA-146b induces the PI3K/Akt/NF-κB signaling pathway to reduce vascular inflammation and apoptosis in myocardial infarction by targeting PTEN , 2018, Experimental and therapeutic medicine.

[30]  D. Heymann,et al.  Osteoprotegerin Induces CD34+ Differentiation in Endothelial Progenitor Cells , 2018, Front. Med..

[31]  Lijuan Hu,et al.  Exosomes derived from endothelial progenitor cells ameliorate acute lung injury by transferring miR‐126 , 2018, Experimental cell research.

[32]  Yasuyuki Fujita,et al.  Autologous Granulocyte Colony‐Stimulating Factor‐Mobilized Peripheral Blood CD34 Positive Cell Transplantation for Hemodialysis Patients with Critical Limb Ischemia: A Prospective Phase II Clinical Trial , 2018, Stem cells translational medicine.

[33]  H. Mizuno,et al.  Human peripheral blood mononuclear cells enriched in endothelial progenitor cells via quality and quantity controlled culture accelerate vascularization and wound healing in a porcine wound model , 2018, Cell transplantation.

[34]  R. Barbet,et al.  VSELs Maintain their Pluripotency and Competence to Differentiate after Enhanced Ex Vivo Expansion , 2018, Stem Cell Reviews and Reports.

[35]  Pengfei Li,et al.  Exosomes from Endothelial Progenitor Cells Improve the Outcome of a Murine Model of Sepsis. , 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

[36]  P. Liu,et al.  A Five‐Year Study of the Efficacy of Purified CD34+ Cell Therapy for Angiitis‐Induced No‐Option Critical Limb Ischemia , 2018, Stem cells translational medicine.

[37]  E. Noiri,et al.  Human Peripheral Blood Mononuclear Cells Incubated in Vasculogenic Conditioning Medium Dramatically Improve Ischemia/Reperfusion Acute Kidney Injury in Mice , 2018, Cell transplantation.

[38]  Y. Hayashizaki,et al.  CD157 Marks Tissue-Resident Endothelial Stem Cells with Homeostatic and Regenerative Properties. , 2018, Cell stem cell.

[39]  Mel S. Lee,et al.  Intra-carotid arterial transfusion of autologous circulatory derived CD34+ cells for old ischemic stroke patients - a phase I clinical trial to evaluate safety and tolerability. , 2018, American journal of translational research.

[40]  Brian M. Rapp,et al.  Adult venous endothelium is a niche for highly proliferative and vasculogenic endothelial colony‐forming cells , 2017, Journal of vascular surgery.

[41]  S. Ran,et al.  Novel role of immature myeloid cells in formation of new lymphatic vessels associated with inflammation and tumors , 2017, Journal of leukocyte biology.

[42]  Alan W. Stitt,et al.  MicroRNA‐containing extracellular vesicles released from endothelial colony‐forming cells modulate angiogenesis during ischaemic retinopathy , 2017, Journal of cellular and molecular medicine.

[43]  R. Hajjar,et al.  Angiogenic Mechanisms of Human CD34+ Stem Cell Exosomes in the Repair of Ischemic Hindlimb , 2017, Circulation research.

[44]  Alan W. Stitt,et al.  Endothelial Progenitors: A Consensus Statement on Nomenclature , 2017, Stem cells translational medicine.

[45]  K. Khosrotehrani,et al.  Functional Definition of Progenitors Versus Mature Endothelial Cells Reveals Key SoxF-Dependent Differentiation Process , 2017, Circulation.

[46]  Mel S. Lee,et al.  Investigated the safety of intra-renal arterial transfusion of autologous CD34+ cells and time courses of creatinine levels, endothelial dysfunction biomarkers and micro-RNAs in chronic kidney disease patients-phase I clinical trial , 2017, Oncotarget.

[47]  A. Quyyumi,et al.  PreSERVE-AMI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients With Left Ventricular Dysfunction Post STEMI. , 2014, Circulation research.

[48]  D. Allan,et al.  Transfer of microRNA-486-5p from human endothelial colony forming cell-derived exosomes reduces ischemic kidney injury. , 2016, Kidney international.

[49]  Amit N. Patel,et al.  Autologous CD34+ Cell Therapy for Refractory Angina: 2-Year Outcomes from the ACT34-CMI Study , 2016, Cell transplantation.

[50]  T. Henry,et al.  The RENEW Trial: Efficacy and Safety of Intramyocardial Autologous CD34(+) Cell Administration in Patients With Refractory Angina. , 2016, JACC. Cardiovascular interventions.

[51]  A. El-Shal,et al.  Comparing the effects of MSCs and CD34+ cell therapy in a rat model of myocardial infarction , 2016, IUBMB life.

[52]  D. Lim,et al.  Transplantation of Immortalized CD34+ and CD34- Adipose-Derived Stem Cells Improve Cardiac Function and Mitigate Systemic Pro-Inflammatory Responses , 2016, PloS one.

[53]  Cheuk-Kwan Sun,et al.  Peripheral blood-derived endothelial progenitor cell therapy prevented deterioration of chronic kidney disease in rats. , 2015, American journal of translational research.

[54]  M. Goligorsky,et al.  The Secretome of Hydrogel‐Coembedded Endothelial Progenitor Cells and Mesenchymal Stem Cells Instructs Macrophage Polarization in Endotoxemia , 2015, Stem cells translational medicine.

[55]  G. Bergers,et al.  Intertwined regulation of angiogenesis and immunity by myeloid cells. , 2015, Trends in immunology.

[56]  Liqiang Gu,et al.  In vitro induction of human adipose-derived stem cells into lymphatic endothelial-like cells. , 2015, Cellular reprogramming.

[57]  Justin L. Mott,et al.  Overview of MicroRNA Biology , 2015, Seminars in Liver Disease.

[58]  X. Loyer,et al.  Bone-marrow-derived very small embryonic-like stem cells in patients with critical leg ischaemia: evidence of vasculogenic potential , 2015, Thrombosis and Haemostasis.

[59]  Jui-Cheng Chen,et al.  Intracerebral Implantation of Autologous Peripheral Blood Stem Cells in Stroke Patients: A Randomized Phase II Study , 2014, Cell transplantation.

[60]  M. Hamady,et al.  Intra‐Arterial Immunoselected CD34+ Stem Cells for Acute Ischemic Stroke , 2014, Stem cells translational medicine.

[61]  B. Zingarelli,et al.  Endothelial progenitor cells and a stromal cell-derived factor-1α analogue synergistically improve survival in sepsis. , 2014, American journal of respiratory and critical care medicine.

[62]  G. Coukos,et al.  Bone marrow-derived cells are implicated as a source of lymphatic endothelial progenitors in human breast cancer , 2014, Oncoimmunology.

[63]  R. Ohls,et al.  Existence, Functional Impairment, and Lung Repair Potential of Endothelial Colony-Forming Cells in Oxygen-Induced Arrested Alveolar Growth , 2014, Circulation.

[64]  S. Mitter,et al.  Vasoreparative Dysfunction of CD34+ Cells in Diabetic Individuals Involves Hypoxic Desensitization and Impaired Autocrine/Paracrine Mechanisms , 2014, PloS one.

[65]  Y. Shiozawa,et al.  Human and murine very small embryonic-like cells represent multipotent tissue progenitors, in vitro and in vivo. , 2014, Stem cells and development.

[66]  T. Ikeda,et al.  Effects of intravenous administration of umbilical cord blood CD34+ cells in a mouse model of neonatal stroke , 2014, Neuroscience.

[67]  H. Masuda,et al.  Autologous G-CSF-Mobilized Peripheral Blood CD34+ Cell Therapy for Diabetic Patients with Chronic Nonhealing Ulcer , 2014, Cell transplantation.

[68]  Yu-zhen Tan,et al.  CD34+VEGFR-3+ progenitor cells have a potential to differentiate towards lymphatic endothelial cells , 2014, Journal of cellular and molecular medicine.

[69]  Guo-Dong Wang,et al.  Inhibition of Lymphangiogenesis of Endothelial Progenitor Cells with VEGFR-3 siRNA Delivered with PEI-alginate Nanoparticles , 2014, International journal of biological sciences.

[70]  Y. Okita,et al.  Phase II clinical trial of CD34+ cell therapy to explore endpoint selection and timing in patients with critical limb ischemia. , 2014, Circulation journal : official journal of the Japanese Circulation Society.

[71]  M. Joseph,et al.  Nanofiber-expanded human umbilical cord blood-derived CD34+ cell therapy accelerates murine cutaneous wound closure by attenuating pro-inflammatory factors and secreting IL-10. , 2014, Stem cell research.

[72]  K. Khosrotehrani,et al.  Prospective Surface Marker‐Based Isolation and Expansion of Fetal Endothelial Colony‐Forming Cells From Human Term Placenta , 2013, Stem cells translational medicine.

[73]  J. H. Lee,et al.  CD34 Hybrid Cells Promote Endothelial Colony-Forming Cell Bioactivity and Therapeutic Potential for Ischemic Diseases , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[74]  Shou-Ching S. Jaminet,et al.  Human white adipose tissue vasculature contains endothelial colony-forming cells with robust in vivo vasculogenic potential , 2013, Angiogenesis.

[75]  D. Newby,et al.  Late Outgrowth Endothelial Cells Resemble Mature Endothelial Cells and Are Not Derived from Bone Marrow , 2013, Stem cells.

[76]  M. Tendera,et al.  Paracrine proangiopoietic effects of human umbilical cord blood-derived purified CD133+ cells--implications for stem cell therapies in regenerative medicine. , 2013, Stem cells and development.

[77]  Shing-Jyh Chang,et al.  Distinct angiogenesis roles and surface markers of early and late endothelial progenitor cells revealed by functional group analyses , 2013, BMC Genomics.

[78]  W. Marston,et al.  A Randomized, Controlled Pilot Study of Autologous CD34+ Cell Therapy for Critical Limb Ischemia , 2012, Circulation. Cardiovascular interventions.

[79]  Xiao-Yan Fu,et al.  The effect of vascular endothelial growth factor C expression in tumor-associated macrophages on lymphangiogenesis and lymphatic metastasis in breast cancer. , 2012, Molecular medicine reports.

[80]  Y. Kurimoto,et al.  Long-term clinical outcome after intramuscular transplantation of granulocyte colony stimulating factor-mobilized CD34 positive cells in patients with critical limb ischemia. , 2012, Atherosclerosis.

[81]  M. Bitzer,et al.  Microparticles and MicroRNAs of Endothelial Progenitor Cells Ameliorate AKI , 2012, Kidney international.

[82]  P. Libby,et al.  Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis , 2012, The Journal of experimental medicine.

[83]  H. Masuda,et al.  R EGENERATIVE M EDICINE Concise Review: Circulating Endothelial Progenitor Cells for Vascular Medicine , 2022 .

[84]  G. Coukos,et al.  The parallel lives of angiogenesis and immunosuppression: cancer and other tales , 2011, Nature Reviews Immunology.

[85]  H. Perlman,et al.  Exosomes From Human CD34+ Stem Cells Mediate Their Proangiogenic Paracrine Activity , 2011, Circulation research.

[86]  T. Henry,et al.  Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina , 2011, Circulation research.

[87]  H. Masuda,et al.  Methodological Development of a Clonogenic Assay to Determine Endothelial Progenitor Cell Potential , 2011, Circulation research.

[88]  M. Grocott,et al.  Acute respiratory distress syndrome and acute lung injury , 2011, Postgraduate Medical Journal.

[89]  Douglas Losordo,et al.  CD34-positive stem cells: in the treatment of heart and vascular disease in human beings. , 2011, Texas Heart Institute journal.

[90]  C. Schmidt‐Weber,et al.  Transforming growth factor-beta: recent advances on its role in immune tolerance. , 2011, Methods in molecular biology.

[91]  B. Gersh,et al.  CD34(+) cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent. , 2011, American heart journal.

[92]  Pilhan Kim,et al.  Podoplanin-Expressing Cells Derived From Bone Marrow Play a Crucial Role in Postnatal Lymphatic Neovascularization , 2010, Circulation.

[93]  Y. Kim,et al.  Bone marrow-derived endothelial progenitor cells confer renal protection in a murine chronic renal failure model. , 2010, American journal of physiology. Renal physiology.

[94]  T. Yamanaka,et al.  Intramuscular Transplantation of G‐CSF‐Mobilized CD34+ Cells in Patients With Critical Limb Ischemia: A Phase I/IIa, Multicenter, Single‐Blinded, Dose‐Escalation Clinical Trial , 2009, Stem cells.

[95]  G. Christofori,et al.  Myeloid Cells Contribute to Tumor Lymphangiogenesis , 2009, PloS one.

[96]  R. Sakthivel,et al.  Ex Vivo Nanofiber Expansion and Genetic Modification of Human Cord Blood-Derived Progenitor/Stem Cells Enhances Vasculogenesis , 2009, Cell transplantation.

[97]  R. Lavi,et al.  Endothelial Progenitor Cells Restore Renal Function in Chronic Experimental Renovascular Disease , 2009, Circulation.

[98]  H. Ott,et al.  Multipotent Mesenchymal Stem Cells Acquire a Lymphendothelial Phenotype and Enhance Lymphatic Regeneration In Vivo , 2009, Circulation.

[99]  P. Obexer,et al.  Endothelial cells from cord blood CD133+CD34+ progenitors share phenotypic, functional and gene expression profile similarities with lymphatics , 2008, Journal of cellular and molecular medicine.

[100]  I. Brink,et al.  Long-term benefit of intracardiac delivery of autologous granulocyte-colony-stimulating factor-mobilized blood CD34+ cells containing cardiac progenitors on regional heart structure and function after myocardial infarct. , 2009, Cytotherapy.

[101]  Xia Zhang,et al.  Interleukin‐10: new perspectives on an old cytokine , 2008, Immunological reviews.

[102]  M. Wong,et al.  Hematopoietic Stem Cells Contribute to Lymphatic Endothelium , 2008, PloS one.

[103]  J. Nielsen,et al.  Novel functions of the CD34 family , 2008, Journal of Cell Science.

[104]  J. Pollard,et al.  Macrophages define the invasive microenvironment in breast cancer , 2008, Journal of leukocyte biology.

[105]  P. Allavena,et al.  The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. , 2008, Critical reviews in oncology/hematology.

[106]  Ju-Young Kim,et al.  Identification of a Novel Role of T Cells in Postnatal Vasculogenesis: Characterization of Endothelial Progenitor Cell Colonies , 2007, Circulation.

[107]  Luigi Biancone,et al.  Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. , 2007, Blood.

[108]  M. Yoder,et al.  Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. , 2007, Experimental hematology.

[109]  A. Reinisch,et al.  Immune Cells Mimic the Morphology of Endothelial Progenitor Colonies In Vitro , 2007, Stem cells.

[110]  R. Raedt,et al.  Endothelial Outgrowth Cells Are Not Derived From CD133+ Cells or CD45+ Hematopoietic Precursors , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[111]  K. Poh,et al.  Intramyocardial Transplantation of Autologous CD34+ Stem Cells for Intractable Angina: A Phase I/IIa Double-Blind, Randomized Controlled Trial , 2007, Circulation.

[112]  T. Asahara,et al.  CD34-Positive Cells Exhibit Increased Potency and Safety for Therapeutic Neovascularization After Myocardial Infarction Compared With Total Mononuclear Cells , 2006, Circulation.

[113]  M. Wong,et al.  Myeloid lineage progenitors give rise to vascular endothelium , 2006, Proceedings of the National Academy of Sciences.

[114]  M. Gnant,et al.  VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: impact on lymphangiogenesis and survival. , 2006, Surgery.

[115]  Hung Li,et al.  Intracerebral Peripheral Blood Stem Cell (CD34+) Implantation Induces Neuroplasticity by Enhancing β1 Integrin-Mediated Angiogenesis in Chronic Stroke Rats , 2006, The Journal of Neuroscience.

[116]  G. Nickenig,et al.  CD34−/CD133+/VEGFR-2+ Endothelial Progenitor Cell Subpopulation With Potent Vasoregenerative Capacities , 2006, Circulation research.

[117]  C. Gentile,et al.  Presence of endothelial progenitor cells, distinct from mature endothelial cells, within human CD146+ blood cells , 2005, Thrombosis and Haemostasis.

[118]  L. Muller,et al.  PAR-1 Activation on Human Late Endothelial Progenitor Cells Enhances Angiogenesis In Vitro With Upregulation of the SDF-1/CXCR4 System , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[119]  K. Maruyama,et al.  Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. , 2005, The Journal of clinical investigation.

[120]  M. Yoder,et al.  Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. , 2005, Blood.

[121]  A. Scheffold,et al.  CD14+CD34low Cells With Stem Cell Phenotypic and Functional Features Are the Major Source of Circulating Endothelial Progenitors , 2005, Circulation research.

[122]  A. Ganser,et al.  Monitoring of Bone Marrow Cell Homing Into the Infarcted Human Myocardium , 2005, Circulation.

[123]  M. Yoder,et al.  Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. , 2005, Blood.

[124]  U. Ikeda,et al.  Repair of Infarcted Myocardium Mediated by Transplanted Bone Marrow–Derived CD34+ Stem Cells in a Nonhuman Primate Model , 2005, Stem cells.

[125]  B. Peters,et al.  Contribution of bone marrow–derived endothelial cells to human tumor vasculature , 2005, Nature Medicine.

[126]  C. Corless,et al.  Transplanted human bone marrow contributes to vascular endothelium. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[127]  G. Stassi,et al.  Transplantation of low dose CD34+Kdr+ cells promotes vascular and muscular regeneration in ischemic limbs , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[128]  K. Pollok,et al.  Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. , 2004, Blood.

[129]  N. Mackman,et al.  PI3K-Akt Pathway Suppresses Coagulation and Inflammation in Endotoxemic Mice , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[130]  H. Naritomi,et al.  Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. , 2004, The Journal of clinical investigation.

[131]  G. Alessandri,et al.  Genetically Engineered Stem Cell Therapy for Tissue Regeneration , 2004, Annals of the New York Academy of Sciences.

[132]  Hyun-Jae Kang,et al.  Characterization of Two Types of Endothelial Progenitor Cells and Their Different Contributions to Neovasculogenesis , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[133]  M. Wong,et al.  Transplanted adult hematopoietic stems cells differentiate into functional endothelial cells. , 2004, Blood.

[134]  James T. Willerson,et al.  Transdifferentiation of Human Peripheral Blood CD34+-Enriched Cell Population Into Cardiomyocytes, Endothelial Cells, and Smooth Muscle Cells In Vivo , 2003, Circulation.

[135]  S. Kliche,et al.  Endothelial progenitor cell culture and differentiation in vitro: a methodological comparison using human umbilical cord blood. , 2003, Cardiovascular research.

[136]  R. Handgretinger,et al.  Biology and Plasticity of CD133+ Hematopoietic Stem Cells , 2003, Annals of the New York Academy of Sciences.

[137]  Toru Suzuki,et al.  Neoendothelialization after peripheral blood stem cell transplantation in humans: a case report of a Tokaimura nuclear accident victim. , 2003, Cardiovascular research.

[138]  Arshed A. Quyyumi,et al.  Circulating Endothelial Progenitor Cells, Vascular Function, and Cardiovascular Risk , 2003 .

[139]  Y. Yoon,et al.  Intramyocardial Transplantation of Autologous Endothelial Progenitor Cells for Therapeutic Neovascularization of Myocardial Ischemia , 2003, Circulation.

[140]  S. Rafii,et al.  VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells. , 2003, Blood.

[141]  K. Shimada,et al.  Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial , 2002, The Lancet.

[142]  D. Soligo,et al.  Differentiation and expansion of endothelial cells from human bone marrow CD133+ cells , 2001, British journal of haematology.

[143]  A M Zeiher,et al.  HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. , 2001, The Journal of clinical investigation.

[144]  S. Fichtlscherer,et al.  Number and Migratory Activity of Circulating Endothelial Progenitor Cells Inversely Correlate With Risk Factors for Coronary Artery Disease , 2001, Circulation research.

[145]  M. Ratajczak,et al.  Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. , 2001, Blood.

[146]  S. Homma,et al.  Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function , 2001, Nature Medicine.

[147]  J. Isner,et al.  Therapeutic Potential of Ex Vivo Expanded Endothelial Progenitor Cells for Myocardial Ischemia , 2001, Circulation.

[148]  B. Christy,et al.  Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. , 2000, The Journal of clinical investigation.

[149]  T. Murohara,et al.  Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. , 2000, The Journal of clinical investigation.

[150]  K. Pantel,et al.  In vitro differentiation of endothelial cells from AC133-positive progenitor cells , 2000 .

[151]  J. Isner,et al.  Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[152]  S. Rafii,et al.  Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. , 2000, Blood.

[153]  R. Hebbel,et al.  Origins of circulating endothelial cells and endothelial outgrowth from blood. , 2000, The Journal of clinical investigation.

[154]  S. Rafii,et al.  Evidence for circulating bone marrow-derived endothelial cells. , 1998, Blood.

[155]  Takayuki Asahara,et al.  Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.

[156]  W. Risau,et al.  Induction of vasculogenesis and hematopoiesis in vitro. , 1992, Development.

[157]  L. Pardanaud,et al.  Relationship between vasculogenesis, angiogenesis and haemopoiesis during avian ontogeny. , 1989, Development.

[158]  T. Doetschman,et al.  Vasculogenesis and angiogenesis in embryonic-stem-cell-derived embryoid bodies. , 1988, Development.